4.7 Letter

About the source and consequences of 18F-FDG brain PET hypometabolism in short and long COVID-19

Journal

Publisher

SPRINGER
DOI: 10.1007/s00259-021-05342-y

Keywords

-

Funding

  1. CAPES [88887.507218/2020-00, 88887.507161/2020-00, 88887.185806/2018-00]
  2. CNPQ [152189/2020-3, 435642/2018-9]
  3. Inserm
  4. Universite de Poitiers
  5. CNPQ/INCT [465671/2014-4]
  6. CNPQ/ZIKA [440763/2016-9]
  7. CNPQ/FAPERGS/PRONEX [16/2551-0000475-7]
  8. FAPERGS [19/2551-0000700-0]
  9. Instituto Serrapilheira [Serra-1912-31365]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease

Nicholas J. Ashton, Andrea L. Benedet, Tharick A. Pascoal, Thomas K. Karikari, Juan Lantero-Rodriguez, Wagner S. Brum, Sulantha Mathotaarachchi, Joseph Therriault, Melissa Savard, Mira Chamoun, Erik Stoops, Cindy Francois, Eugeen Vanmechelen, Serge Gauthier, Eduardo R. Zimmer, Henrik Zetterberg, Kaj Blennow, Pedro Rosa-Neto

Summary: CSF p-tau epitopes increase early in the development of AD pathology and are a primary candidate for detecting incipient Aβ pathology.

EBIOMEDICINE (2022)

Article Biochemistry & Molecular Biology

Lifelong Exposure to a Low-Dose of the Glyphosate-Based Herbicide RoundUp® Causes Intestinal Damage, Gut Dysbiosis, and Behavioral Changes in Mice

Ingrid Del Castilo, Arthur S. Neumann, Felipe S. Lemos, Marco A. De Bastiani, Felipe L. Oliveira, Eduardo R. Zimmer, Amanda M. Rego, Cristiane C. P. Hardoim, Luis Caetano M. Antunes, Flavio A. Lara, Claudia P. Figueiredo, Julia R. Clarke

Summary: This study investigated the effects of long-term exposure to GBH-RUp on the gut environment in mice and found that it caused morphological and functional changes in the gut, which correlated with behavioral changes similar to those observed in patients with neurodevelopmental disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

Bisphenol S favors hepatic steatosis development via an upregulation of liver MCT1 expression and an impairment of the mitochondrial respiratory system

Bessem Mornagui, Raja Rezg, Cendrine Repond, Luc Pellerin

Summary: Bisphenol S (BPS), a substitute for bisphenol A (BPA), may act as an obesogenic endocrine disruptor and affect monocarboxylate transporters and mitochondrial respiratory system in the liver, leading to the development of hepatic steatosis.

JOURNAL OF CELLULAR PHYSIOLOGY (2022)

Article Geriatrics & Gerontology

Functional Cognitive Disorder Presents High Frequency and Distinct Clinical Profile in Patients With Low Education

Wyllians Vendramini Borelli, Priscylla Nunes de Senna, Wagner Scheeren Brum, Artur Francisco Schumacher-Schuh, Eduardo R. Zimmer, Marcia Lorena Fagundes Chaves, Raphael Machado Castilhos

Summary: This study investigated the frequency of Functional Cognitive Disorder (FCD) among individuals with low education and found that FCD was the most common diagnosis in this population. Compared to Neurodegenerative Disorders (NDD), individuals with FCD were younger, had higher cognitive test scores, and higher levels of depression. Therefore, strategies to identify and manage FCD in primary care settings can benefit both patients and healthcare systems.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Editorial Material Cell Biology

Comment on Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases

Eduardo R. Zimmer, Tharick A. Pascoal, Pedro Rosa-Neto, Agneta Nordberg, Luc Pellerin

Summary: This statement suggests that astrocytes play a major role in the microglia-dependent modulation of FDG-PET.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Letter Gastroenterology & Hepatology

Reply to: Is NAFLD a key driver of brain dysfunction?

Anna Hadjihambi, Luc Pellerin

JOURNAL OF HEPATOLOGY (2023)

Article Biochemistry & Molecular Biology

Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adults

Douglas T. Leffa, Joao Pedro Ferrari-Souza, Bruna Bellaver, Cecile Tissot, Pamela C. L. Ferreira, Wagner S. Brum, Arthur Caye, Jodie Lord, Petroula Proitsi, Thais Martins-Silva, Luciana Tovo-Rodrigues, Dana L. Tudorascu, Victor L. Villemagne, Ann D. Cohen, Oscar L. Lopez, William E. Klunk, Thomas K. Karikari, Pedro Rosa-Neto, Eduardo R. Zimmer, Brooke S. G. Molina, Luis Augusto Rohde, Tharick A. Pascoal

Summary: The genetic liability for attention-deficit/hyperactivity disorder (ADHD) is associated with cognitive decline and the development of Alzheimer's Disease (AD) pathology, especially in individuals with increased amyloid-beta (Aβ) deposition.

MOLECULAR PSYCHIATRY (2023)

Article Clinical Neurology

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography

Joseph Therriault, Marie Vermeiren, Stijn Servaes, Cecile Tissot, Nicholas J. Ashton, Andrea Lessa Benedet, Thomas K. Karikari, Juan Lantero-Rodriguez, Wagner S. Brum, Firoza Z. Lussier, Gleb Bezgin, Jenna Stevenson, Nesrine Rahmouni, Peter Kunach, Yi-Ting Wang, Jaime Fernandez-Arias, Kely Quispialaya Socualaya, Arthur C. Macedo, Joao Pedro Ferrari-Souza, Pamela C. L. Ferreira, Bruna Bellaver, Douglas T. Leffa, Eduardo R. Zimmer, Paolo Vitali, Jean-Paul Soucy, Gallen Triana-Baltzer, Hartmuth C. Kolb, Tharick A. Pascoal, Paramita Saha-Chaudhuri, Serge Gauthier, Henrik Zetterberg, Kaj Blennow, Pedro Rosa-Neto

Summary: This study investigates the association between cerebrospinal fluid (CSF) and plasma p-tau biomarkers and the hallmark pathologies of Alzheimer's disease (AD): amyloid-beta plaques and tau neurofibrillary tangles. The results suggest that p-tau is mainly associated with amyloid-beta accumulation, indicating that p-tau abnormalities may be an early event in the pathogenesis of AD.

JAMA NEUROLOGY (2023)

Article Neurosciences

Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance within the Clinical Spectrum of Alzheimer's Disease

Marina Tedeschi Dauar, Tharick Ali Pascoal, Joseph Therriault, Jared Rowley, Sara Mohaddes, Monica Shin, Eduardo R. Zimmer, Simon Fristed Eskildsen, Vladimir S. Fonov, Serge Gauthier, Judes Poirier, Pedro Rosa-Neto

Summary: This study assessed the association between cognitive measures and pathophysiological events in Alzheimer's disease patients, specifically focusing on delayed episodic memory tests. The findings revealed correlations between memory scores and regional amyloid deposition and brain metabolism across different stages of the disease.

BRAIN SCIENCES (2023)

Article Clinical Neurology

Blood-brain barrier integrity impacts the use of plasma amyloid-β as a proxy of brain amyloid-β pathology

Bruna Bellaver, Albert Puig-Pijoan, Joao Pedro Ferrari-Souza, Douglas T. Leffa, Firoza Z. Lussier, Pamela C. L. Ferreira, Cecile Tissot, Guilherme Povala, Joseph Therriault, Andrea L. Benedet, Nicholas J. Ashton, Stijn Servaes, Mira Chamoun, Jenna Stevenson, Nesrine Rahmouni, Marie Vermeiren, Arthur C. Macedo, Aida Fernandez-Lebrero, Greta Garcia-Escobar, Irene Navalpotro-Gomez, Oscar Lopez, Dana L. Tudorascu, Ann Cohen, Victor L. Villemagne, William E. Klunk, Serge Gauthier, Eduardo R. Zimmer, Thomas K. Karikari, Kaj Blennow, Henrik Zetterberg, Marc Suarez-Calvet, Pedro Rosa-Neto, Tharick A. Pascoal

Summary: The permeability of the blood-brain barrier (BBB) may affect the levels of brain-derived proteins in the blood, which in turn can impact the relationship between brain and blood biomarkers. The study found that BBB permeability influenced the relationship between plasma A beta(42/40) and CSF A beta(42/40) as well as A beta-PET positivity, but did not significantly impact the relationship between brain and plasma p-tau levels.

ALZHEIMERS & DEMENTIA (2023)

Article Chemistry, Medicinal

A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases

Igor C. Fontana, Debora G. Souza, Diogo O. Souza, Antony Gee, Eduardo R. Zimmer, Salvatore Bongarzone

Summary: The excitatory amino acid transporter 2 (EAAT2) is crucial for the clearance and recycling of glutamate, the major excitatory neurotransmitter in the brain. Dysfunctions in EAAT2 can lead to neurodegenerative diseases, such as ALS and AD. Detecting EAAT2 in the living human brain is important for improving diagnosis and therapy for these diseases. This article discusses the role of EAAT2 and presents potential activators for therapy and molecular imaging tools for diagnosis.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Capsicum baccatum Red Pepper Prevents Cardiometabolic Risk in Rats Fed with an Ultra-Processed Diet

Aline Rigon Zimmer, Bianca Franco Leonardi, Eduardo Rigon Zimmer, Alexandre Pastoris Muller, Grace Gosmann, Luis Valmor Cruz Portela

Summary: This study evaluated the protective effects of Capsicum baccatum red pepper on metabolic syndrome induced by an ultra-processed diet in rats. The results showed that oral administration of C. baccatum along with the ultra-processed diet prevented adipose tissue accumulation, reduced total cholesterol and LDL levels, and improved glucose metabolism, all commonly associated with metabolic syndrome. The study suggests that C. baccatum red pepper is a secure and enriched source of bioactive compounds promising to protect against pathological processes associated with metabolic syndrome.

METABOLITES (2023)

Article Clinical Neurology

Race-related population attributable fraction of preventable risk factors of dementia: A Latino population-based study

Wyllians Vendramini Borelli, Carolina Rodrigues Formoso, Andrei Bieger, Pamela Lukasewicz Ferreira, Eduardo R. Zimmer, Tharick Ali Pascoal, Marcia Lorena Fagundes Chaves, Raphael Machado Castilhos

Summary: Risk factors for dementia vary among different races, and hearing loss is the most important contributor to overall population attributable fraction in all races. Public policies aimed at reducing preventable risk factors for dementia should consider the race of the target populations.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2023)

Article Clinical Neurology

Promoting diversity and overcoming publication barriers in Latin American neuroscience and Alzheimer's disease research: A call to action

Mychael V. Lourenco, Wyllians Vendramini Borelli, Claudia Duran-Aniotz, Eduardo R. Zimmer, Shamyr Sulyvan de Castro

Summary: Alzheimer's disease (AD) is a global health issue, with immense socioeconomic burden on low- and middle-income countries (LMIC) as well as high-income countries. However, LMICs face disparities in resources and barriers to publishing in international journals, including funding constraints, language barriers, and high article processing charges. The equalization of publication fees by publishing companies could help reduce scientific inequality and improve AD research capacity in LMICs.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2023)

Article Pharmacology & Pharmacy

Endocannabinoid System Biomarkers in Alzheimer's Disease

Pamela C. L. Ferreira, Bruna Bellaver, Guilherme Povala, Wagner S. Brum, Cecile Tissot, Atef Badji, Matthew E. Sloan, Andrea L. Benedet, Pedro Rosa-Neto, Nicholas J. Ashton, Tharick A. Pascoal, Antoine Leuzy, Eduardo R. Zimmer

Summary: Endocannabinoid system biomarkers are associated with the progression and pathological features of Alzheimer's disease. Although not specific enough for diagnosis, they hold promise for prognosis, drug-target engagement, and a better understanding of the disease.

CANNABIS AND CANNABINOID RESEARCH (2023)

No Data Available